The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors
Abstract
Human papillomavirus (HPV) 16 is involved in causing cervical cancer. The E6 and E7 proteins of HPV 16 immortalize human keratinocytes and this is due, at least in part, to inactivation of the tumor suppressor proteins p53 and pRB. These tumor suppressor proteins also regulate the expression of pro- and antiangiogenic factors by cells. For this reason, experiments were conducted to determine whether the expression of E6 and E7 in primary keratinocytes alters the phenotype of these cells such that they express diminished levels of antiangiogenic factors and/or increased levels of proangiogenic factors. To avoid variances in experimental observations, pools of human foreskin keratinocytes from multiple sources were infected with recombinant retrovirus expressing HPV 16 E6 and E7 or control retrovirus. Gene array analysis, RT-PCR, ELISAs and Western blotting showed that in cells expressing HPV 16 E6 and E7, expression levels of two potent angiogenesis inhibitors, thrombospondin-1 and maspin, were lower compared to controls. Additionally, major angiogenesis inducers, interleukin-8 and vascular endothelial growth factor (VEGF), were increased relative to controls. VEGF can be produced as multiple splice variants, all of which are required for the formation of patent blood vessels. The expression of HPV 16 E6 and E7 in keratinocytes augmented expression of VEGF 121, 145, 165 and 189. These observations show that HPV 16 E6 and E7 alter the phenotype of primary keratinocytes, diminis…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inactivation of p53 by high-risk E6, also downregulates angiogenic inhibitors, TSP-1 and maspin, while upregulating VEGF-inducing angiogenesis [293,294,295,296,297]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [293]
Citations
Cites
Multiple control of interleukin-8 gene expression
Hoffmann, E., Dittrich-Breiholz, O., Holtmann, H., & Kracht, M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.5.847 · Cited by 1,058
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967
Research works printed but not linked: 43
- Ai W, Toussaint E and Roman A . (1999). J. Virol., 73, 4220–4229. · DOI
- Antinore MJ, Birrer MJ, Patel D, Nader L and McCance DJ . (1996). EMBO J., 15, 1950–1960. · DOI · Paper page
- Arbeit JM, Munger K, Howley PM and Hanahan D . (1994). J. Virol., 68, 4358–4368. · DOI
- Bequet-Romero M and Lopez-Ocejo O . (2000). Biochem. Biophys. Res. Commun., 277, 55–61. · DOI
- Bouck N . (1996). Biochim. Biophys. Acta, 1287, 63–66. · DOI
- Bouck N, Stellmach V and Hsu SC . (1996). Adv. Cancer Res., 69, 135–174. · DOI
- Charnock-Jones DS, Sharkey AM, Rajput-Williams J, Burch D, Schofield JP, Fountain SA, Boocock CA and Smith SK . (1993). Biol. Reprod., 48, 1120–1128. · DOI
- Cinatl Jr J, Kotchetkov R, Scholz M, Cinatl J, Vogel JU, Driever PH and Doerr HW . (1999). Am. J. Pathol., 155, 285–292. · DOI
- Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W and Bouck NP . (1999). Science, 285, 245–248. · DOI
- Desaintes C, Hallez S, Van Alphen P and Burny A . (1992). J. Virol., 66, 325–333. · DOI
- Dobbs SP, Hewett PW, Johnson IR, Carmichael J and Murray JC . (1997). Br. J. Cancer, 76, 1410–1415. · DOI
- Ferrara N, Houck KA, Jakeman LB, Winer J and Leung DW . (1991). J. Cell Biochem., 47, 211–218. · DOI
- Folkman J and Shing Y . (1992). J. Biol. Chem., 267, 10931–10934. · DOI
- Gillitzer R and Goebeler M . (2001). J. Leukocyte Biol., 69, 513–521. · DOI · Paper page
- Gomez-Manzano C, Fueyo J, Jiang H, Glass TL, Lee HY, Hu M, Liu JL, Jasti SL, Liu TJ, Conrad CA and Yung WK . (2003). Ann. Neurol., 53, 109–117. · DOI
- Gonzalez SL, Stremlau M, He X, Basile JR and Munger K . (2001). J. Virol., 75, 7583–7591. · DOI · Paper page
- Grassmann K, Rapp B, Maschek H, Petry KU and Iftner T . (1996). J. Virol., 70, 2339–2349. · DOI
- Guidi AJ, Abu-Jawdeh G, Berse B, Jackman RW, Tognazzi K, Dvorak HF and Brown LF . (1995). J. Natl. Cancer Inst., 87, 1237–1245. · DOI
- Halbert CL, Demers GW and Galloway DA . (1991). J. Virol., 65, 473–478. · DOI · Paper page
- Hanahan D and Folkman J . (1996). Cell, 86, 353–364. · DOI · Paper page
- Hanahan D and Weinberg RA . (2000). Cell, 100, 57–70. · DOI · Paper page
- Harada H, Nakagawa K, Saito M, Kohno S, Nagato S, Furukawa K, Kumon Y, Hamada K and Ohnishi T . (2003). Cancer Lett., 191, 109–119. · DOI
- Houck KA, Ferrara N, Winer J, Cachianes G, Li B and Leung DW . (1991). Mol. Endocrinol., 5, 1806–1814. · DOI
- Huang SM and McCance DJ . (2002). J. Virol., 76, 8710–8721. · DOI · Paper page
- Igarashi H, Esumi M, Ishida H and Okada K . (2002). Cancer, 95, 47–53. · DOI
- Jeon S and Lambert PF . (1995). Proc. Natl. Acad. Sci. USA, 92, 1654–1658. · DOI
- Kodama J, Seki N, Tokumo K, Hongo A, Miyagi Y, Yoshinouchi M, Okuda H and Kudo T . (1999). Eur. J. Cancer, 35, 485–489. · DOI
- Leung DW, Cachianes G, Kuang WJ, Goeddel DV and Ferrara N . (1989). Science, 246, 1306–1309. · DOI
- Lopez-Ocejo O, Viloria-Petit A, Bequet-Romero M, Mukhopadhyay D, Rak J and Kerbel RS . (2000). Oncogene, 19, 4611–4620. · DOI · Paper page
- Matlashewski G, Schneider J, Banks L, Jones N, Murray A and Crawford L . (1987). EMBO J., 6, 1741–1746. · DOI · Paper page
- Munger K and Howley PM . (2002). Virus Res., 89, 213–228. · DOI
- Nees M, Geoghegan JM, Hyman T, Frank S, Miller L and Woodworth CD . (2001). J. Virol., 75, 4283–4296. · DOI
- Pattison S, Skalnik DG and Roman A . (1997). J. Virol., 71, 2013–2022. · DOI
- Rheinwald JG . (1980). Methods Cell Biol., 21A, 229–254. · DOI
- Rhim JS, Tsai WP, Chen ZQ, Chen Z, Van Waes C, Burger AM and Lautenberger JA . (1998). Carcinogenesis, 19, 673–681. · DOI
- Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM . (1990). Cell, 63, 1129–1136. · DOI · Paper page
- Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC and Abraham JA . (1991). J. Biol. Chem., 266, 11947–11954. · DOI · Paper page
- Tjiong MY, van d V ten Kate FJ, Tjong AHS, ter Schegget J, Burger MP and Out TA . (1999). Gynecol. Oncol., 73, 285–291. · DOI
- Vikhanskaya F, Bani MR, Borsotti P, Ghilardi C, Ceruti R, Ghisleni G, Marabese M, Giavazzi R, Broggini M and Taraboletti G . (2001). Oncogene, 20, 7293–7300. · DOI
- Volpert OV, Dameron KM and Bouck N . (1997). Oncogene, 14, 1495–1502. · DOI
- von Knebel DM, Rittmuller C, zur Hausen H and Durst M . (1992). Int. J. Cancer, 51, 831–834. · DOI
- Wazer DE, Liu XL, Chu Q, Gao Q and Band V . (1995). Proc. Natl. Acad. Sci. USA, 92, 3687–3691. · DOI
- Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E and Srivastava S . (2000). J. Biol. Chem., 275, 6051–6054. · DOI · Paper page
Cited by
Basukala, O., & Banks, L. (2021) · Viruses · doi:10.3390/v13101892 · Cited by 137
Martínez-Cruz, A. B., Santos, M., Lara, M. F., Segrelles, C., Ruiz, S., Moral, M., Lorz, C., García-Escudero, R., & Paramio, J. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3049 · Cited by 65
Involvement of RB gene family in tumor angiogenesis
Gabellini, C., Del Bufalo, D., & Zupi, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209631 · Cited by 47
Metadata
- Authors
- Toussaint-Smith, E., Donner, D. B., & Roman, A.
- Venue
- Oncogene
- Published
- 2004-02-16
- Volume
- 23
- Issue
- 17
- Pages
- 2988-2995
- ISSN
- 0950-9232
- 1476-5594
- Cited by
- 119
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review